A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
Go to Source
Author: Ann E. Marimow
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml
A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
Go to Source
Author: Ann E. Marimow
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml